Cancer patients undergoing treatment can experience relief from nausea and vomiting with the help of a cost-effective anti-nausea pill. However, some patients are facing challenges due to coverage limits imposed by pharmacy benefit managers.
These restrictions on the quantity of tablets patients can receive have raised concerns among doctors, who believe that such limitations can negatively impact patient care. Pharmacy benefit managers defend their limits as a measure to prevent overuse and offer alternative solutions to obtain more tablets.
